Panther Orthopedics Mid-Term Clinical Outcomes with the PUMA System

Panther Orthopedics PUMA System

Panther Orthopedics announced exceptional mid-term clinical outcomes for PUMA System™, the first and only FDA-cleared superelastic syndesmosis device featuring a spring-like design for initial and continuous compression without the need to over-tension.

PUMA received FDA 510(k) clearance in 2018, and the company has since closed...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us